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ABSTRACT The interactions of 15N-labeled amantadine, an antiinﬂuenza A drug, with DMPC bilayers were investigated by solid-
state NMR and by a 12.6-ns molecular dynamics (MD) simulation. The drug was found to assume a single preferred orientation and
location when incorporated in these bilayers. The experimental and MD computational results demonstrate that the long axis of
amantadine is on average parallel to the bilayer normal, and the amine group is oriented toward the headgroups of the lipid bilayers.
The localization of amantadine was determined by paramagnetic relaxation and by the MD simulation showing that amantadine is
within the interfacial region and that theamine interactswith the lipid headgroupandglycerol backbone,while thehydrocarbonportion
of amantadine interacts with the glycerol backbone and much of the fatty acyl chain as it wraps underneath the drug. The lipid
headgroup orientation changes on drug binding as characterized by the anisotropy of 31P chemical shielding and 14N quadrupolar
interactions and by the MD simulation.
INTRODUCTION
Like many other drugs, amantadine, which inhibits conduc-
tance by the M2 proton channel from influenza virus, is
lipophilic. The ability of drugs to cross hydrophobic barriers
to reach their targets will affect their pharmokinetics and
toxicology. The partitioning of drugs into membranes not
only influences drug transport, distribution, selectivity, and
efficiency but also alters the physical properties of mem-
branes (1–3). In addition, many lipophilic ligands partitioning
into membranes appear to have a preferred location and
orientation that facilitates interactions with receptors through
lateral diffusion (3,4). Thus, the characterization of drug
interactions with membranes is important for further drug
development. Here, the interaction of amantadine with a lipid
bilayer is characterized by solid-state NMR and by molecular
dynamics (MD) simulation.
Amantadine (1-aminoadamantane) is a licensed drug that
has been used for the prophylaxis and treatment of influenza A
viral infections. The target of amantadine is the M2 proton
channel, which is critical for viral replication (5,6). The M2
protein has 96 residueswith a single 19-residue transmembrane
helix. The functional structure of the M2 channel is minimally
tetrameric (5). Electrophysiological studies demonstrate that
the M2 protein selectively conducts protons through a variety
of membrane systems, such as the oocytes of Xenopus laevis
(7), mammalian cells (8), and planar lipid bilayers (9).
Significant suppression of proton conductance by amantadine
or rimantadine in these systems is well documented (10,11).
The transmembrane domain of M2 (M2-TMD) also forms a
proton-selective channel in lipid bilayers that is sensitive to
amantadine (12). However, the mechanism by which amanta-
dine compromises M2 proton conductance is still controver-
sial. Most frequently, amantadine is regarded as a channel
blocker. Alternatively, it may act as an allosteric inhibitor by
which amantadine binds outside the pore region and presum-
ably from the lipid environment, thereby inducing a confor-
mational change to the channel and inducing closure of the
channel. In addition, it has recently been speculated that
amantadine may interfere with the channel mechanisms by
which protons are conducted (13,14). Amantadine and its
derivatives have also been studied as possible drugs against the
human immunodeficiency virus-1 (HIV-1) and Parkinson’s
disease (15,16).
A variety of biophysical methods, including neutron and
x-ray diffraction (17), solution NMR (18), and EPR (19),
have been applied to study the association between aman-
tadine and cellular membranes. The partition coefficient of a
spin-labeled amantadine analog in 1,2-dimyristoyl-sn-glycero-
3-phosphocholine (DMPC) vesicles, measured by EPR, is
11.2 at 45C (19), whereas the partition coefficient of aman-
tadine in DMPC/1,2-dihexanoyl-sn-glycero-3-phosphocholine
(DHPC) bicelles, measured by a solution NMR diffusion
method, is 27.6 (18). It is therefore clear that amantadine has
a high affinity for membranes while having significant
solubility in the aqueous phase. Neutron and x-ray diffrac-
tion studies (17) indicate that a majority of the drug occupies
a region around the headgroups of DOPC, although these
diffraction studies appear to suggest that a portion of these
molecules bind near the bilayer center. On the other hand, the
drug was found to be around phosphate groups as well as the
hydrocarbon chains by saturation transfer difference exper-
iments in solution NMR (18).
Orientation-dependent spin interactions can be observed by
solid-state NMR from uniformly aligned samples; this pro-
vides restraints on the orientation of the observed molecular
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site, and data on motional averaging can be obtained from
unoriented samples. In addition, water-soluble relaxation
agents can be added to the membrane samples to characterize
the depth of a molecular site within the membrane environ-
ment. Here, we describe the alignment, location, and charge
state of amantadine in DMPC bilayers and the influence of
amantadine on these bilayers. Solid-state NMR methods and




The 15N-amantadineHCl was synthesized according to published proce-
dures (20). 15N-labeled acetonitrile (Isotech, Miamisburg, Ohio) was used
to provide the 15N source. The final product was verified by mass and 1H
solution NMR spectroscopy.
Oriented samples of hydrated DMPC bilayers were prepared by first
dissolving DMPC (100 mg) in 5 ml trifluoroethanol (TFE). TFE was
removed by rotary evaporation and dried under high vacuum, and 15 ml of
20 mM citrate-borate-phosphate (CBP) buffer (;37C, pH 8.0) with 1 mM
ethylenediamine tetra-acetic acid (EDTA) was added to the dried mixture
and shaken at 37C. This lipid suspension was bath sonicated for 10 min
intermittently. The sonicated suspension was loaded into a 3 kDaMW cutoff
dialysis bag. The dialysis bag was placed in 1 liter of 20 mM CBP buffer
overnight to adjust the pH of liposomes. For a sample with amantadine, a
desired concentration of amantadineHCl (Fisher Scientific, GA) in 5 ml
CBP buffer was added to the DMPC vesicle suspension (20 ml). The
suspension was incubated at room temperature overnight and pelleted in 2.5
h by ultracentrifugation at 196,000 3 g. The pH value of the pellet was
inferred from a measurement of the supernatant. The pellet was agitated at
37C for 1 h until it became fluid. This viscous fluid was spread onto 50
glass slides (5.7 mm3 12.0 mm) (Marienfeld Glassware, BadMargentheim,
Germany) and dried in a humidity (70–75% relative humidity) chamber
using a N2 atmosphere. The dehydrated slides were stacked together,
inserted into a glass tube, and rehydrated in a 96% humidity (saturated
K2SO4) chamber at 40C for 1 wk. The resultant sample had between 20 and
30 waters/lipid molecule. Finally, the glass tube was sealed.
NMR experiments
Static 31P NMR experiments were conducted on a Bruker DMX-300 at 303
K using an NHMFL 31P/1H double resonance probe, and H3PO4 was used as
a reference for 0 ppm. 15N NMR experiments were performed on a 400MHz
spectrometer using an NHMFL static 15N/1H probe with a flat coil.
Typically, an 800-ms cross-polarization contact time, 6-s recycle delay, and
50-kHz B1 field for both the
1H and 15N channels were used. The 15N
chemical shift was referenced to 15NH4NO3 at 26 ppm relative to liquid
ammonia. The 14N spectra were obtained using a quadrupolar echo sequence
(21) on an 830-MHz spectrometer at room temperature with an NHMFL
probe. 13C MAS NMR were performed on a 300-MHz wide-bore spec-
trometer with a 4-mm double-resonance Bruker MAS probe operated at a
spinning frequency of 6 kHz and a temperature of 303 K.
MD simulation
The MD simulation was performed using AMBER 8 (22). Because AMBER
does not have force field parameters for the DMPC lipid molecule,
CHARMM27 parameters (23) were employed for the lipid in the simula-
tions. The charges for amantadine were developed using Gaussian 03 (24)
and the restraint electrostatic potential (RESP) fitting method (25) (Table 1),
and topology parameters were assigned according to the general AMBER
force field (26). The average temperature was maintained at 310 K (above
the DMPC phase transition temperature, 296 K) with a 2-ps coupling time
constant, and the average pressure was maintained at 1 bar with anisotropic
scaling and a 2-ps relaxation time (27). The periodic boundary condition was
enforced. The nonbonded cutoff was set to 9.0 A˚, and the nonbonded list
was updated with a 2.0-A˚ skin width. The particle mesh Ewald method (28–
30) was applied to calculate long-range electrostatic interactions. All bond
lengths involving hydrogen were constrained with SHAKE and RATTLE
algorithms (31,32), allowing an integration time step of 2 fs. The coordinates
were saved every 1 ps for analysis.
The simulated system consisted of one amantadine molecule and 68
DMPC lipid molecules (34 DMPC molecules in each leaflet), forming a
hydrated bilayer with 3014 TIP3P (33) water molecules. Initially the
amantadine molecule was placed near the center of the preequilibrated
bilayer (courtesy of Turgut Bastug (34)). To start the simulation, the system
was energy minimized with gradually decreasing harmonic restraints to
remove bad contacts. The system was then heated to 310 K for 40 ps at
constant volume. Thereafter, the simulation was continued at constant
temperature and pressure for 12.6 ns. The last 10 ns of the trajectory was
analyzed for this study (see Fig. 6).
RESULTS
Charged state of amantadine in DMPC bilayers
As indicated in Fig. 1, for a sample of 15N-labeled
amantadine in hydrated DMPC bilayers prepared at pH
2.0, the static 15N signal was distinguished by an apparent
isotropic resonance around 64 ppm. The spectrum at pH 8.0
displayed a typical axially symmetric powder pattern, with
s? ¼ 49 ppm and s? ¼ 66 ppm. We ascribe the signal at pH
2.0 to the positively charged amantadine in which the
primary amine has very little chemical shift anisotropy and a
changed isotropic average. The broadening of the symmetric
resonance may be the result of chemical exchange. At pH
8.0, the amantadine is a free base leading to a significant
chemical shift anisotropy. Throughout this article, results at
pH 8.0, involving the neutral instead of charged form of
amantadine, are reported.
The aligment of amantadine in DMPC bilayers
Macroscopically aligned NMR samples were prepared at pH
8.0, and the orientations of the phospholipid bilayers on the
glass plates were characterized by 31P-NMR shown in the
left column of Fig. 2. The molar ratio of amantadine to lipid
is 1:20. The 31P and 15N spectra of an unoriented sample
(Fig. 2, A and D, respectively) show typical powder pattern
TABLE 1 Partial charges of amantadine by ab initio and RESP
combined calculations
Atom Charge Atom Charge
N 1.12499 HN 0.37895
Ca 0.79573
Cb 0.37719 Hb 0.06968
Cg 0.3982 Hg 0.08143
Cd 0.35686 Hd 0.02657
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spectra, implying a homogeneous sample preparation. When
the sample was aligned between glass plates and oriented
with the bilayer normal perpendicular to the magnetic field
direction, the 31P resonance was observed at approximately –
18 ppm (Fig. 2 B), and the 15N resonance from amantadine
was observed to be close to 69 ppm (Fig. 2 E). When the
sample was rotated by 90 such that the bilayer normal was
parallel to the magnetic field, the 31P resonance shifted to 36
ppm (Fig. 2 C), and the 15N resonance shifted to 50 ppm
(Fig. 2 F). The results indicate that the amantadine takes on
a preferential orientation and does not rotate isotropically
in the membrane. The resonances in the aligned sample
correspond approximately to parallel and perpendicular
values of the powder sample, indicating that amantadine is
rotating rapidly about the bilayer normal on the chemical
shift time scale.
Inﬂuence of amantadine on the dynamics and
orientation of phospholipid headgroups
31P and 14N NMR spectra were recorded to probe directly the
zwitterionic P-O-CH2-CH2-N
1(CH3)3 headgroup electric
dipole of DMPC. Such spectra of DMPC/amantadine
liposomes at different molar ratios are shown in Fig. 3. In
pure DMPC bilayers, the chemical shift anisotropy (CSA, sk
 s?) of 31P was 47 ppm (Fig. 3 A), and the quandrupolar
splitting (measured as the separation of the n? components)
of the choline group of DMPC was ;11 kHz (Fig. 3 D).
When 5 mol % amantadine was incorporated into the lipid
bilayers, the 31P CSA increased to 56 ppm (Fig. 3 B), and the
14N quadrupolar splitting decreased to 8 kHz (Fig. 3 E).
When the amantadine mole fraction was increased to 10%,
the 31P CSA continued to increase to 60 ppm (Fig. 3 C), and
14N quadrupolar splitting decreased to 7 kHz (Fig. 3 F). It is
clearly shown that amantadine affects the headgroup orien-
tation and/or dynamics in this concentration range, which is
considerably higher than that under pharmaceutical condi-
tions. Here the high concentration was used to help identify
the location of amantadine within the membrane. The
relatively large 14N quadrupolar coupling constant of the
amantadine amine group was not observed here. It has
previously been shown that the features of 31P and 14N
anisotropy are sensitive to variations in the DMPC surface
potential (35–37). Our results suggest that the P-N1 dipole
orientation changes on incorporation of amantadine and
FIGURE 1 Static 15N spectra of amantadine in hydrated randomly oriented
DMPC bilayers at pH 2.0 (A) and pH 8.0 (B) at 30C in a 400-MHz spec-
trometer.
FIGURE 2 Static 31P spectra (left column) of DMPC using 300-MHz
spectrometer and 15N spectra (right column) of amantadine in hydrated
DMPC bilayers using 400-MHz spectrometer: (A and D) no alignment, (B
and E) perpendicular, and (C and F) parallel with respect to the static
magnetic field (Bo). The experiments were performed at 30C and pH 8.0.
The molar ratio of amantadine to lipid is 1:20.
FIGURE 3 Static 31P spectra (left column) from a 300-MHz spectrom-
eter and 14N spectra from an 830-MHz spectrometer (right column) of
randomly oriented hydrated DMPC in the presence of amantadine in mole
percent: 0% (A and D), 5% (B and E), and 10% (C and F) amantadine. The
experiments were performed at 30C and pH 8.0.
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hence changes the surface potential at these high amantadine
concentrations.
Location of the amantadine in the DMPC bilayers
Fig. 4 displays 31P and 15N spectra of aligned DMPC/
amantadine samples (molar ratio 20:1) in the absence (Fig. 4,
A and C) and in the presence of 1.5 mol % Mn21. The 31P
resonance around 36 ppm (Fig. 4 A) demonstrates that the
lipid bilayers are well aligned. This signal was barely
observable when 1.5% Mn21 was added to the sample
because of the broadening induced by the paramagnetic
relaxation enhancement of Mn21 interacting with the
membrane surface. However, the amantadine 15N signal at
50 ppm (Fig. 4 C) was still observed in the same sample that
showed no 31P signal, although the intensity was greatly
decreased. Note that in these spectra the 15N signal from the
DMPC choline site was not observed because of the low
natural abundance and fast motion leading to poor cross-
polarization efficiency. These observations suggest that the
nitrogen atom of amantadine is less accessible to Mn21 than
the phosphates of DMPC.
Mn21 is often employed as a paramagnetic relaxation
agent to detect the insertion depth of lipophilic ligands in
model membranes (38,39). It binds at the membrane surface
(i.e., the phosphates) and dephases the lipid 13C signals
monotonically with increasing distance of the lipid methy-
lene groups from the membrane surface. Thus, comparison
of the intensity of amantadine carbons with that of the lipid
carbons permits the relative depth of the amantadine with
respect to the lipid moieties to be extracted. The 13C CP-
MAS spectra of amantadine in the DMPC lipid bilayers at
different concentrations of Mn21 and the amantadine
resonance assignments from literature values (40) are shown
in Fig. 5. With amantadine partitioned into DMPC bilayers,
the chemical shifts of the amantadine resonances labeled
with asterisks appear to be only slightly shifted in frequency,
but their line width is much narrower when a dry powder of
amantadine (Fig. 5 A) is dissolved into the bilayers (Fig. 5 B). To simplify the interpretation, resonances of the lipid head-
group are circled and identified in Fig. 5 E. When 1.5%
Mn21 is present (Fig. 5 C), the lipid headgroup signals are no
longer observable because of the broadening effect of Mn21;
however, the carbonyl carbon from the fatty acyl chain is still
observable, though broadened. Similarly, the signal from the
amantadine a-carbon is broadened but to a lesser extent than
the b-carbons. In the presence of 5% Mn21 (Fig. 5 D), the
intensities of amantadine and most of the lipid signals
decrease substantially except for the C12, C13, and methyl
signals, which are in the bilayer center and are not influenced
by Mn21. Therefore, by comparing the dephasing rate of
amantadine signals using the 13C resonance of the lipid as a
reference intensity, it can be deduced that the amantadine
signals dephase at rates a. b. g, suggesting that the Ca is
closer to Mn21 at the bilayer surface than the Cg. This
FIGURE 4 Static 31P spectra (left column) from a 300-MHz spectrom-
eter of DMPC and 15N spectra (right column) from a 400-MHz spectrometer
of amantadine (AMT/lipid, 1:20 molar ratio) in aligned hydrated DMPC
bilayers (parallel with B0) in the presence of Mn
21 in mole percent: 0% (A
and C) and 1.5%Mn21 (B and D). The experiments were performed at 30C
and pH 8.0.
FIGURE 5 13C CP-MAS spectra of (A) dry powder sample of amantadine
(the free base form, the molecule is shown to the left and the resonance assign-
ments are labeled in the spectrum). (B) Amantadine in hydrated DMPC lipid
bilayers: the signals from amantadine are labeled with asteriks. (C) The same
sample as inB in the presence of 1.5%mol%MnCl2. (D) The same sample as in
B in the presence of 5 mol %MnCl2. The experiments were performed at 30C
and pH 8.0. The molar ratio of amantadine to lipid is 1:5.
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observation implies that the amine group of amantadine is
directed toward the bilayer surface, whereas the Cg/Cd end of
amantadine is toward the bilayer center, as would be expected.
More specifically, the data show that the Ca of amantadine has
a similar dephasing rate as that of the carbonyl carbon of
DMPC, suggesting that the two carbons are located at a
similar depth in the membrane.
MD simulation
The alignment of amantadine in DMPC bilayer
Throughout the whole 12.6-ns simulation, amantadine
remained in the upper leaflet of the membrane bilayer (Fig.
6). The average surface area per DMPC lipid of 59.46 0.6 A˚2
over the last 10 ns of the trajectory is consistent with
experimental observations (41,42). The alignment of amanta-
dine in the DMPC bilayer was measured by the angle between
the amantadine Ca-N vector and the membrane normal (Fig. 7,
black). Consistentwith theNMRdata presented earlier, amanta-
dine is oriented in the upright direction in the simulation, with
the most probable tilt of 30 between the Ca-N vector and the
membrane normal (Fig. 7, red).
Location of amantadine in DMPC bilayer
In agreement with the NMR data, as shown in Fig. 8, during
the simulation the amantadine amine resides mainly between
the phosphate and carbonyl groups of DMPC, with distances
of the amine from the central plane of the membrane ranging
from 11.7 A˚ to 18.3 A˚ for 90% of the time. For reference, the
average distances of the choline, phosphate, and carbonyl
groups over the 34 DMPC lipid molecules in the upper leaflet
are also shown in Fig. 8. Although the average location of the
headgroups in the bilayer is very stable, the headgroups of
the individual lipid molecules vary widely along the
direction of the membrane normal. Minimum and maximum
distances of the choline, phosphate, and carbonyl groups
from the central plane through the 10-ns trajectory were 9 to
29, 10 to 26, and 3 to 22 A˚, respectively. Such limits of a
dynamic range were not observed by NMR experiments
because of the rarity of the event and the small population.
The hydrophilic interfacial region of the bilayer was thus
quite fluid, explaining the wide range of amantadine amine
distances from the central plane (Fig. 8, red).
Inﬂuence of amantadine on the DMPC headgroup orientation
Interactions between amantadine and DMPC lipids influence
the conformation of the lipids. The average angle of P-N
dipoles to the bilayer normal in the DMPC headgroups near
amantadine (Fig. 9, green) was different from those away
from amantadine (Fig. 9, blue) in the upper leaflet. Interest-
ingly, the average angle of the headgroup dipoles near
amantadine is correlated with the depth of amantadine in the
bilayer during the 10-ns trajectory (Fig. 8). When the
FIGURE 6 The membrane-amantadine-water system in MD simulation.
DMPC lipid molecules, amantadine, and water box are represented by line,
sphere, and surface, respectively.
FIGURE 7 The angle of amantadine Ca-N vector to the membrane
normal along the 10-ns trajectory (black) and its distribution with the peak at
30 (red).
FIGURE 8 The relative depth of the amantadine (red, nitrogen atom) with
respect to the DMPC lipid molecules in the upper leaflet. Distances from
the bilayer central plane (0 A˚) along the 10-ns trajectory are shown. For
comparison, the average distance of nitrogen (black), phosphorus (green), and
oxygen (blue) atoms in choline, phosphate, and carbonyl groups from the
membrane center are shown as well. The broken black line shows the
distribution of the amantadine amine location with a peak at 15 A˚.
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amantadine amine had the same depth as the phosphate and
choline groups (around 2, 5, and 8 ns), the average angle of
the P-N vectors from the bilayer normal was smaller (30 to
60); in contrast, at the beginning and end of the 10-ns
trajectory, when the amantadine amine was below the level
of the carbonyl groups, the P-N angle increased (;80) to
that for the lipid molecules distant from amantadine. The
large P-N angles are thought to be caused by intramolecular
interactions between choline and carbonyl groups within the
DMPC molecules (43). Amantadine appears to disrupt these
intramolecular interactions when the amine interacts with the
lipid headgroup. This influence on the P-N vector is likely
to correspond with the change in the average P-N1 dipole
orientation observed by NMR.
Inﬂuence of amantadine on lipid acyl chains
Details of the amantadine-membrane interactions were
further analyzed. Heavy atoms of DMPC lipid molecules
within 4 A˚ of amantadine were identified in each snapshot
along the 10-ns trajectory. Based on this 4 A˚ criterion,
amantadine on average interacted with 3.6 lipid molecules
simultaneously, involving 8.3 heavy atoms of the lipids.
Amantadine interacted with the carbonyl groups 94% of the
time, with the phosphate groups 72% of the time, and with
acyl chains 87% of the time. Inspection of the conformations
of the surrounding lipid molecules revealed that their acyl
chains were bent to fill in the space below amantadine; the
acyl chains effectively wrapped around the bottom of
amantadine. A representative snapshot showing the confor-
mations of lipids around amantadine is presented in Fig. 10.
This detailed picture from the MD simulation, with the aman-
tadine amine located around the phosphate and carbonyl
groups but with acyl chains curled up to wrap around the
bottom of the drug molecule, indicates how amantadine can
interact with the lipid headgroups and the distal end of the
fatty acyl chains at the same time.
DISCUSSION
The results from this work build on a considerable literature
using various techniques to characterize amantadine inter-
actions with model membranes. Chou and co-workers (18)
have elegantly characterized the partition coefficient for
amantadine into a DMPC bilayer environment through the
use of soluble bicelle samples. Here, the solid-state NMR
data and simulation results indicate that amantadine parti-
tions into the membrane with a preferred equilibrium loca-
tion in the interfacial region, such that the amine can be in a
relatively hydrophilic domain and the amantadine hydrocar-
bon can be in the hydrophobic region of the bilayer. This is
similar to the equilibrium position for tryptophan side chains
of membrane proteins (44,45). Amantadine is a weak base
with a pKa of 9 determined in aqueous solution (46), but it is
well known that pKas can change by several pH units for
titratable sites that interact with a membrane environment
(47,48). The 15N powder pattern results clearly show that,
under the conditions used here, we are observing the un-
charged amine at pH 8 and the charged amine at pH 2, where
no significant chemical shift anisotropy is observed.
Interestingly, the 31P chemical shift anisotropy, which
was shown here to increase in magnitude when amantadine
was added to DMPC bilayers, is the opposite of what was
observed by Epand and co-workers (49) when they added
amantadine to bilayers of dielaidoylphosphatidylethanol-
amine (DEPE). This is likely caused by the high sensitivity
of the 31P CSA to the phospholipid headgroup orientation
and the very different headgroup conformation for PE and
PC. Although mixed phases have been characterized by 31P
CSA for amantadine preparations at elevated temperature,
FIGURE 9 The average angle of DMPC P-N vectors in the upper leaflet
with respect to the membrane normal, within 12 A˚ of amantadine (green)
and that of the outside lipid molecules (blue) along the 10-ns trajectory.
Amantadine location (red) and P-N angle (green) show an anti-correlation. FIGURE 10 A snapshot of theMD simulation at 3.8 ns from the beginning
of 10-ns trajectory.Lipids around andaway fromamantadine in the upper leaflet
are shown by stick and surface representations, respectively. Amantadine is
represented by spheres. Carbon, nitrogen, oxygen, hydrogen, and phosphorus
atoms are colored in cyan, blue, red, white, and brown, respectively.
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there was no evidence here that amantadine induced a
nonbilayer DMPC phase at 30C.
Previous studies of the influence of amantadine on lipid
bilayers have generated confusing conclusions about the
location of amantadine within the lipid bilayer. Neutron and
x-ray diffraction results led to a proposal that the uncharged
amantadine had two populations, one that was nearly at the
bilayer center and one at the water/bilayer interface (17).
This proposal was further supported by EPR studies of spin-
labeled amantadine (19). Both the experimental and com-
putational results reported here suggest that there is a single
homogeneous, although dynamic, population in the mem-
brane. The location of amantadine along the normal to the
bilayer appears to be between the two populations described
from the diffraction study.
Chou and co-workers (18) have used NMR experiments to
transfer magnetization from the lipid environment to the Cg-
H sites of amantadine to qualitatively assess the location of
the drug within bicelles. Although they showed no transfer from
the choline methyls, there was transfer from the glycerol
backbone and the entire fatty acyl chain to amantadine. Here,
it was shown that all of the amantadine resonances were
influenced by the water-soluble Mn21 relaxation agent,
whereas the terminal carbons on the fatty acyl chains were
not affected. The computational results showed rotational
excursions of the amantadine that might expose the g and d
carbons occasionally to the hydrophilic surface, explaining
the induced relaxation by Mn21 and the saturation transfer
results from the glycerol backbone to the Cg-H sites on
amantadine. Although the terminal carbons of the fatty acyl
chains remain far removed from the hydrophilic surface and
the Mn21 relaxation agent, our simulation results show that
the fatty acyl chains wrap around the amantadine hydrocar-
bon moiety, potentially accounting for the close approach of
the terminal methyl with amantadine Cg-H and thereby
explaining the saturation transfer results with the terminal
methyl groups. In addition, it may help to explain the
diffraction results that suggested that there was a population
of amantadine near the bilayer center. Here, the simulations
show not only that the methyls can be close to amantadine
but also how the bilayer can be significantly distorted, which
may help to explain the diffraction data.
Consequently, the data from bicelles are consistent with
those observed here in bilayers, although we would argue
based on our observation of the amantadine amine that
amantadine does interact with the bilayer surface. In addition
to a preferred position in the membrane, amantadine has a
preferred equilibrium orientation and does not tumble freely
in the lipid bilayer. This is in contrast with the results from
Wang et al. (18), which suggest that amantadine tumbles
freely in the bicelle based on the observation of the same 1H
line width of amantadine in bicelles and in organic solvent.
However, here it is clear that amantadine has a unique position,
orientation, and dynamic amplitude in liquid crystalline lipid
bilayers that do not permit it to cross the membrane, at least not
rapidly. The results here and in the literature suggest that the
drug partitions extensively in themembrane and is bound at the
hydrophilic/hydrophobic lipid interface. Although we believe
that amantadine binds toM2protein on its tetrameric symmetry
axis, this suggests that amantadine binds to M2 protein via the
small aqueous population of the drug. Furthermore, despite
being lipophilic, amantadine does not appear to readily cross
the bilayer center due to its interaction with the bilayer surface.
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